Central neurocytomas are generally noncancerous (benign) brain tumors in the ventricles, which are the fluid-filled spaces within the brain.
These lesions may obstruct spinal fluid flow and/or put pressure on surrounding structures, causing symptoms including headaches and confusion.
Surgery is the standard treatment for central neurocytomas.
At UPMC, the preferred surgical treatment for central neurocytomas is Neuroendoport® surgery.
Neuroendoport surgery gives surgeons access to the tumor through a dime-size channel. This minimally invasive approach offers benefits such as:
To diagnose central neurocytoma, your doctor will ask about your symptoms and may order imaging tests.
Central neurocytoma symptoms may include:
Imaging and radiology studies, such as MRI or CT scans, can identify central neurocytomas.
Surgery is the standard treatment for central neurocytomas.
Neuroendoport® surgery is a minimally invasive treatment option for tumors within the ventricles (fluid spaces) or deep-seated tumors within the substance of the brain.
A narrow tube or port allows surgeons to access these tumors through a tiny incision in the scalp, in contrast to traditional brain surgery.
At UPMC, our neurosurgeons will evaluate you thoroughly to find the path that is least disruptive to your brain, critical nerves, and ability to return to normal functioning.
Neuroendoport® Surgery
This animation illustrates the removal of a metastasis using the Neuroendoport technique.
